Showing results (681-690 of 1,050) with videos related to
Sort By:
Pageof 105
JACC. Clinical Electrophysiology|June 27, 2024
Long-Term Changes in Atrial Arrhythmia Burden After Renal Denervation Combined With Pulmonary Vein Isolation: SYMPLICITY-AFLarry Chinitz, Michael Böhm, Rudolph Evonich, et al.International Journal of Cardiology. Heart & Vasculature|May 16, 2022
Global longitudinal strain differentiates physiological hypertrophy from maladaptive remodelingYvonne Bewarder, Lucas Lauder, Saarraaken Kulenthiran, et al.European Journal of Heart Failure|March 25, 2015
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudyMichael Böhm, Jeffrey S Borer, John Camm, et al.Respiratory Research|October 25, 2023
Mechanical thrombectomy in intermediate- and high-risk acute pulmonary embolism: hemodynamic outcomes at three monthsLucas Lauder, Patricia Pérez Navarro, Felix Götzinger, et al.Journal of the American Heart Association|October 29, 2021
Comparison of Long-Term Outcomes for Responders Versus Non-Responders Following Renal Denervation in Resistant HypertensionKarl Fengler, Paul Reimann, Karl-Philipp Rommel, et al.Journal of Hypertension|October 21, 2015
Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistanceSebastian Ewen, Bodo Cremers, Markus R Meyer, et al.Journal of Translational Medicine|June 10, 2016
Modulation of the sympathetic nervous system by renal denervation prevents reduction of aortic distensibility in atherosclerosis prone ApoE-deficient ratsMathias Hohl, Dominik Linz, Peter Fries, et al.Journal of the American College of Cardiology|October 21, 2015
Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal DenervationFelix Mahfoud, Stefan Tunev, Sebastian Ewen, et al.Journal of the American College of Cardiology|June 13, 2020
Renal Denervation in High-Risk Patients With HypertensionFelix Mahfoud, Giuseppe Mancia, Roland Schmieder, et al.Journal of Hypertension|September 13, 2023
A randomized, placebo-controlled, trial to assess the photosensitizing, phototoxic and carcinogenic potential of hydrochlorothiazide in healthy volunteersFelix Götzinger, Mathias Hohl, Lucas Lauder, et al.Pageof 105